The Jan Vishwas (Amendment of Provisions) Bill, 2026, cleared by both Houses of Parliament, introduces key changes across the health sector aimed at simplifying compliance while maintaining strong public health safeguards.
The legislation underscores the government’s push toward a trust-based governance model by reducing the regulatory burden on individuals and businesses and ensuring that penalties are proportionate to the nature of violations.
A major highlight of the reforms is the shift from criminal penalties especially imprisonment for minor procedural lapses to a system of graded monetary penalties. According to the Union Health Ministry, this marks a transition to a more facilitative regulatory environment, while retaining strict action for serious offences that could impact public health and safety.
The amendments cover several important laws, including the Drugs and Cosmetics Act, 1940; the Pharmacy Act, 1948; the Food Safety and Standards Act, 2006; the Clinical Establishments (Registration and Regulation) Act, 2010; and the National Commission for Allied and Healthcare Professions Act, 2021.
Under the Drugs and Cosmetics Act, provisions have been revised to replace imprisonment with financial penalties and introduce a structured adjudication system. Minor violations particularly those related to cosmetics that are not spurious or adulterated will now be handled through civil penalties instead of court proceedings. Procedural lapses such as failure to maintain records or submit information will also fall under this mechanism.
The reforms also introduce adjudicating authorities at both central and state levels, with a defined process that includes show-cause notices, personal hearings, and an appellate system. This is expected to ease the burden on courts, reduce litigation, and speed up resolution of minor compliance issues, especially benefiting the cosmetics industry.
Changes to the Pharmacy Act, 1948 focus on modernising penalties and increasing accountability through higher financial fines, aligning the law with current regulatory practices.
Similarly, updates to the Food Safety and Standards Act aim to ensure stricter enforcement while maintaining proportional penalties, striking a balance between regulatory oversight and ease of doing business.
The Clinical Establishments Act has also been revised to prioritise monetary penalties for non-compliance in cases where patient safety is not immediately at risk, encouraging corrective measures without criminal action.
Further, amendments to the National Commission for Allied and Healthcare Professions Act strengthen compliance requirements while ensuring penalties remain proportionate and effective as deterrents.
Overall, the reforms bring greater alignment across multiple health laws, promoting consistency, predictability, and clarity in enforcement. By reducing regulatory fragmentation and simplifying compliance, the changes aim to create a more efficient ecosystem for stakeholders across the health sector.
The involvement of 23 ministries highlights a coordinated, whole-of-government approach to improving the regulatory framework, reinforcing the government’s commitment to enhancing ease of doing business and ease of living.
Collectively, these measures are expected to boost compliance, cut down litigation, and build trust between regulators and stakeholders, while continuing to safeguard public health and national interest.
